Eli N. Deal
- Internal Medicine top 2%
- Cardiology and Cardiovascular Medicine top 10%
- Epidemiology
- Surgery
- Pulmonary and Respiratory Medicine
- Co-authors
- Scott T. MicekRichard M. ReichleyJames M. HollandsMarin H. KollefMark ThoelkeCatherine WongBrian F. GagePaul E. Milligan
- Topics
- Atrial Fibrillation Management and Outcomes (6 papers)Venous Thromboembolism Diagnosis and Management (6 papers)Antibiotic Resistance in Bacteria (4 papers)
- Partner nations
- United StatesTürkiye
In The Last Decade
Eli N. Deal
19 papers receiving 560 citations
Peers
Comparison fields: 5 of 82
- Internal Medicine 190
- Cardiology and Cardiovascular Medicine 170
- Epidemiology 152
- Surgery 140
- Pulmonary and Respiratory Medicine 69
Countries citing papers authored by Eli N. Deal
This map shows the geographic impact of Eli N. Deal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli N. Deal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli N. Deal more than expected).
Fields of papers citing papers by Eli N. Deal
This network shows the impact of papers produced by Eli N. Deal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli N. Deal. The network helps show where Eli N. Deal may publish in the future.
Co-authorship network of co-authors of Eli N. Deal
This figure shows the co-authorship network connecting the top 25 collaborators of Eli N. Deal. A scholar is included among the top collaborators of Eli N. Deal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli N. Deal. Eli N. Deal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 49 | |
| 3 | 34 | |
| 4 | 7 | |
| 5 | 17 | |
| 6 | 99 | |
| 7 | 10 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 21 | |
| 11 | 33 | |
| 12 | 5 | |
| 13 | 132 | |
| 14 | 45 | |
| 15 | 29 | |
| 16 | 12 | |
| 17 | 25 | |
| 18 | 8 | |
| 19 | 37 | |
| 20 | 1 |
About Eli N. Deal
Eli N. Deal is a scholar working on Internal Medicine, Critical Care and Intensive Care Medicine and Applied Microbiology and Biotechnology, having authored 21 papers that have together received 568 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (6 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Antibiotic Resistance in Bacteria (4 papers). The work is most often cited by research in Internal Medicine (190 citations), Family Practice (18 citations) and Critical Care and Intensive Care Medicine (42 citations). Eli N. Deal has collaborated with scholars based in United States and Türkiye. Frequent co-authors include Scott T. Micek, Richard M. Reichley, James M. Hollands, Marin H. Kollef, Mark Thoelke, Catherine Wong, Brian F. Gage, Paul E. Milligan, Tzu‐Fei Wang and Andrew Labelle. Their work appears in journals such as Blood, Critical Care Medicine and Anesthesia & Analgesia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.